Rizou, A.E.I.; Nasi, G.I.; Paikopoulos, Y.; Bezantakou, D.S.; Vraila, K.D.; Spatharas, P.M.; Dimaki, V.D.; Papandreou, N.C.; Lamari, F.N.; Chondrogianni, N.;
et al. A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer’s Disease. Biomedicines 2023, 11, 1357.
https://doi.org/10.3390/biomedicines11051357
AMA Style
Rizou AEI, Nasi GI, Paikopoulos Y, Bezantakou DS, Vraila KD, Spatharas PM, Dimaki VD, Papandreou NC, Lamari FN, Chondrogianni N,
et al. A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer’s Disease. Biomedicines. 2023; 11(5):1357.
https://doi.org/10.3390/biomedicines11051357
Chicago/Turabian Style
Rizou, Aikaterini E. I., Georgia I. Nasi, Yiorgos Paikopoulos, Dimitra S. Bezantakou, Konstantina D. Vraila, Panagiotis M. Spatharas, Virginia D. Dimaki, Nikos C. Papandreou, Fotini N. Lamari, Niki Chondrogianni,
and et al. 2023. "A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer’s Disease" Biomedicines 11, no. 5: 1357.
https://doi.org/10.3390/biomedicines11051357
APA Style
Rizou, A. E. I., Nasi, G. I., Paikopoulos, Y., Bezantakou, D. S., Vraila, K. D., Spatharas, P. M., Dimaki, V. D., Papandreou, N. C., Lamari, F. N., Chondrogianni, N., & Iconomidou, V. A.
(2023). A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer’s Disease. Biomedicines, 11(5), 1357.
https://doi.org/10.3390/biomedicines11051357